SPARC196.80

Sun Pharma Advanced Research Company Ltd.

· Pharma & Health
₹ CrorePeersSTARSHILPAMEDSUPRIYATHYROCARERUBICONVIYASHYATHARTHPARKHOSPSMcap ₹6,386 Cr
Comp Set
In ₹ Crore except Per Share
Latest Annual
SPARC
FY26
STAR
FY26
SHILPAMED
FY26
SUPRIYA
FY25
Peer
Median
Valuation — at last close
P/E4.11×20.07×75.80×47.94× -91%
P/B4.77×3.54×7.12×5.33× -11%
EV/EBITDA4.34×13.66×43.85×28.76× -85%
Market Cap₹6,386 Cr₹11,162 Cr₹18,445 Cr₹14,804 Cr -57%
Growth
Revenue CAGR 3Y95.98%9.62%13.59%11.61% +727%
Revenue CAGR 5Y7.94%11.30%9.62%
Revenue YoY (latest Q)314.11%13.01%44.90%28.95% +985%
Net Income YoY (latest Q)59.94%56.73%115.16%85.94% -30%
Profitability
EBITDA Margin85.08%19.04%28.25%23.64% +260%
Net Income Margin82.65%11.82%15.81%13.82% +498%
Return on Common Equity116.20%17.66%9.39%13.53% +759%
Return on Capital Employed112.12%17.93%11.02%14.47% +675%
Return on Assets71.55%8.29%6.57%7.43% +863%
Credit & Quality
Total Debt/Equity0.42×0.53×0.25×0.00×0.25× +68%
Interest Coverage46.54×4.05×5.36×4.71× +889%
Scale — latest FY
Revenue / Total Income₹1,879 Cr₹4,859 Cr₹1,539 Cr₹3,199 Cr -41%
Net Income₹1,553 Cr₹575 Cr₹243 Cr₹409 Cr +280%
Total Assets₹2,171 Cr₹6,927 Cr₹3,706 Cr₹1,112 Cr₹3,706 Cr -41%
EPS₹47.86₹60.34₹12.44₹36.39 +32%
Book Value per Share₹41.26₹341.68₹132.47₹237.08 -83%
◆ best value in the comp set per metric · Δ = subject vs median of the other companies.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.